MeRho-Az compound: Clinical Trials

2 trials of MeRho-Az compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow MeRho-Az compound: new trials by email Literature Review of MeRho-Az compound trials Research Report on MeRho-Az compound

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Inflammatory Agent in Sinusitis
AZ compound, Collection of Biological Specimens, Intranasal corticosteroid - Nasal Polyps
Phase 2CompletedNorthwestern University432016-06-202022-05-25
Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
AZ compound, Placebo - Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH)
Phase 2TerminatedUniversity of Alabama at Birmingham932015-11-012024-03-01

Conditions studied

Nasal Polyps (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Sponsors

Northwestern University (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (1)

Top investigators

Anju T Peters, MD (1)  ·  Rita Basu, MD (1)

Results publications

PMID 35524339